BALCAO · PHARMACEUTICAL PREPARATIONS · SMALL CAP
BetterLife Pharma Inc. BETRF
11 fiscal years on record · USD · FY2018 reported · SEC filings only
CAD -9.1M
Growth
—
Revenue, FY2018 · full 11-year series below
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
—
ROE
No chart to show — the reason differs by year; see each year in the table below.
Each USD of equity lost 530 cents this year.
The 11-year record
11 fiscal years
Every figure from documents filed with the SEC · USD
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
row low → row highnegative
| Metric | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | · | · | · | · | · | · | · | · | · | · | · |
| Operating income $B | · | · | −0.0 | −0.0 | −0.0 | · | · | · | · | · | · |
| EBITDA $B | · | · | · | −0.0 | −0.0 | · | · | · | · | · | · |
| Income tax $B | · | · | · | · | · | · | · | · | · | · | · |
| Net income CAD B | −0.0 | −0.0 | · | · | · | −0.0 | 0.0 | 0.0 | −0.0 | −0.0 | −0.0 |
| EPS, diluted CAD | −0.10 | 0.00 | · | · | · | −0.20 | · | · | · | · | · |
| Dividend / sh $ | · | · | · | · | · | · | · | · | · | · | · |
| Payout % | · | · | · | · | · | · | · | · | · | · | · |
| ROE % | −529.6 | · | · | · | · | · | · | · | · | · | · |
| Shares out B | 0.10 | 0.08 | 0.08 | 0.07 | 0.07 | 0.01 | 0.04 | · | · | · | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 11 failures in 34 reconciliationsAUDITED
Reconciled in 1 of 19 fiscal years. 42 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente11 failures
ActivityPharmaceutical Preparations
Listed onOTC market
Incorporated inoutside the United States — SEC code A1
Fiscal year endsJanuary 31
Data on record since2008